NT-proBNP is superior to BNP for predicting first cardiovascular events in the general population: The Heinz Nixdorf Recall Study

This publication has 27 references indexed in Scilit:

• B‐type natriuretic peptide predicts stroke of presumable cardioembolic origin in addition to coronary artery calcification
  European Journal of Neurology, 2014
• B-type natriuretic peptide: distribution in the general population and the association with major cardiovascular and coronary events—The Heinz Nixdorf Recall Study
  Clinical Research in Cardiology, 2013
• Natriuretic Peptide–Based Screening and Collaborative Care for Heart Failure
  JAMA, 2013
• Predicting risk of coronary events and all-cause mortality: role of B-type natriuretic peptide above traditional risk factors and coronary artery calcium scoring in the general population: the Heinz Nixdorf Recall Study
  European Journal of Preventive Cardiology, 2013
• Improving the Primary Prevention of Cardiovascular Events by Using Biomarkers to Identify Individuals With Silent Heart Disease
  JACC, 2012
• Coronary Risk Stratification, Discrimination, and Reclassification Improvement Based on Quantification of Subclinical Coronary Atherosclerosis
  JACC, 2010
• Biochemistry of B-type natriuretic peptide – where are we now?
  Clinical Chemistry and Laboratory Medicine (CCLM), 2008
• NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients
  European Heart Journal, 2005
• Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
  New England Journal of Medicine, 2004
• Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
  New England Journal of Medicine, 2002